6 May 2021

Deciphex Makes Key Appointments to Strengthen Team in Advance of Mid 2021 Clinical Market Entry

DUBLIN, Ireland, May 4 2021 - Deciphex, a leading provider of digital pathology and AI-powered services, announced that it has appointed Prof Runjan Chetty as Chief Medical Officer, Luke Benko as Vice President of Global Pathology Services and Chris Polley as Clinical Business Manager UK. These key appointments bring excellent core capabilities that will enable Deciphex to break into the global clinical market.

Newly appointed Chief Medical Officer, Prof Chetty is an internationally regarded Anatomical Pathologist/Histopathologist with a speciality interest in GI pathology, will oversee and strengthen global clinical development within Deciphex. Prof Chetty, who brings a tremendous wealth of knowledge and expertise in the clinical pathology arena, was previously the Program Medical Director & Chief/Professor of Pathology at University Health Network & University of Toronto.

Prof Runjan Chetty - Chief Medical Officer

“I was attracted to Deciphex because they are a dynamic company whose foray into the clinical sphere is based on quality and excellence. It is an exciting venture that fills a niche using state of the art hard and software, in particular the development and implementation of diagnostic algorithms that will potentially change the diagnostic landscape.”

Luke Benko, Vice President of Global Pathology Services joins Deciphex from IONpath where he served as the Vice President Sales Worldwide. With nearly two decades of working in the digital pathology industry, in companies such as Leica Biosystems, Applied Spectral Imaging and Flagship Biosciences, Benko has developed both high-performance sales teams and record growth in both US and international markets. Benko will lead Deciphex’s clinical commercial team, which includes customer implementation, global technical support, account management, and managed services.

Luke Benko - VP Global Pathology Services

“I was excited to join a team of Digital Pathology experts from various disciplines and backgrounds at Deciphex. They are a very motivated team and the technology impressed me with it's level of attention given to streamlining pathology workflows and user interfaces. It's a very versatile portfolio, with opportunities to grow and make a real impact in medicine.”

Chris Polley, Clinical Business Manager UK has worked in the Digital Pathology sector for over two decades bringing with him a wealth of experience in helping define and create pathways to bring innovation to the clinical market. Polley joins Deciphex from Philips where he served as Oncology Solutions Lead. He has held a wide range of managerial roles in companies such as Leica Microsystems, Leica Biosystems and Philips. Polley will lead Deciphex’s clinical market adoption in the UK.

Chris Polley - Clinical Business Manager UK

“With nearly 30 years experience in the field of anatomical pathology I have seen many advancements in cancer diagnostics. Deciphex's use of AI empowered digital pathology will help continue that trend by helping reduce the time to diagnosis whilst increasing diagnostic confidence. Supporting pathologists with our internationally recognised network Deciphex will help positively impact the lives of many patients and it is this goal that motivates me in my daily work.”

The extensive experience of Prof Chetty, Benko and Polley will drive Deciphex’s global clinical growth strategy for 2021.

Donal O’Shea - Chief Executive Officer

“As we prepare to enter the clinical market, we are delighted to be able to assemble such a strong clinical leadership with many collective years of experience.  Runjan, Luke and Chris bring considerable expertise to the company in areas where we needed support.  Our clinical plans are truly novel and we look forward to announcing these closer to our launch date”

About Deciphex

Deciphex is an Irish-based software company focused on developing digital pathology-based solutions for clinical and research pathology. Our ambition is to deliver solutions that provide tangible productivity benefits to pathologists, eliminating low-level tasks so they can focus on the critical content. We believe that digital pathology combined with artificial intelligence will help make pathologists work more efficiently in the future, offering a solution to the pending challenges in supply/demand in pathology services. Deciphex plans to be at the forefront of this revolution with cleverly positioned solutions that deliver on the biggest problems facing pathology today.

return to news

Contact Details

Invent Buidling at DCU

Ireland

Deciphex
DCU Alpha Building, Innovation Campus,
11 Old Finglas Rd, Glasnevin, Co. Dublin

Call: +353 1 582 7193

Email: Info@deciphex.com

Twitter: @deciphex

USA Headquarters Building

USA

Deciphex Inc.
1012 95th Street, Naperville,
Chicago, Illinois

Call: +1 203 305 1675

Email: andrew.fink@deciphex.com

USA Headquarters Building

UK

Deciphex
Unit S04, Exeter Science Park Centre,
6 Babbage Way, Exeter

Call: +44 1 29730 2245

Email: Info@deciphex.com

Email Us

The details you submit will be used so that we can contact you in relation to your query either by email or your preferred method of contact. Read our privacy policy here.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form
Copyright Deciphex 2021
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.